Activated platelets interact with lung cancer cells through P-selectin glycoprotein ligand-1

Pathology and Oncology Research

Volumn 18, Issue 4, 2012, Pages 989-996

  Gong, Liang ^a   Cai, Yun ^a   Zhou, Xiangdong ^a   Yang, Heping ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Lung cancer; P selectin; Platelet activation; Pselectin glycoprotein ligand 1; RNA interference

Indexed keywords

MESSENGER RNA; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; SHORT HAIRPIN RNA;

ADULT; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT;

ADULT; ANALYSIS OF VARIANCE; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPRECIPITATION; LUNG NEOPLASMS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM METASTASIS; PLATELET ACTIVATION; PROGNOSIS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84868468674     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-012-9531-y     Document Type: Article

References (24)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics. CA Cancer J Clin 57:43-66
2. Inamura K, Ishikawa Y (2010) Lung cancer progression and metastasis from the prognostic point of view. Clin Exp Metastasis 27:389-397
3. Geiger TR, Peeper DS (2009) Metastasis mechanisms. Biochim Biophys Acta 1796:293-308
4. Joyce JA, Pollard JW (2009) Microenvironmental regulation of metastasis. Nat Rev Cancer 9:239-252
5. Borsig L (2008) The role of platelet activation in tumor metastasis. Expert Rev Anticancer Ther 8:1247-1255
6. Sierko E, Wojtukiewicz MZ (2007) Inhibition of platelet function, does it offer a chance of better cancer progression control? Semin Thromb Hemost 33:712-721
7. Kunita A, Kashima TG, Morishita Y, FukayamaM, Kato Y, Tsuruo T, Fujita N (2007) The platelet aggregation-inducing factor aggrus/podoplanin promotes pulmonary metastasis. Am J Pathol 170:1337-1347
8. Gonzalez Barcala FJ, Garcia Prim JM, Moldes Rodriguez M, AlvarezFernandez J, Rey Rey MJ, Pose Reino A, Valdes Cuadrado L (2010) Platelet count: association with prognosis in lung cancer. Med Oncol 27:357-362
9. Ludwig RJ, Schön MP, Boehncke WH (2007) P-selectin: a common therapeutic target for cardiovascular disorders, inflammation and tumour metastasis. Expert Opin Ther Targets 11:1103-1117
10. Dimitroff CJ, Descheny L, Trujillo N, Kim R, Nguyen V, Huang W, Pienta KJ, Kutok JL, Rubin MA (2005) Identification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cells. Cancer Res 65:5750-5760
11. Baïsse B, Galisson F, Giraud S, Schapira M, Spertini O (2007) Evolutionary conservation of P-selectin glycoprotein ligand-1 primary structure and function. BMC Evol Biol 14:166
12. Raes G, Ghassabeh GH, Brys L, Mpofu N, Verschueren H, Vanhecke D, De Baetselier P (2007) The metastatic T-cell hybridoma antigen/P-selectin glycoprotein ligand 1 is required for hematogenous metastasis of lymphomas. Int J Cancer 121:2646-2652
13. Baumann K, Kowalczyk D, Gutjahr T, Pieczyk M, Jones C, Wild MK, Vestweber D, Kunz H (2009) Sulfated and non-sulfated glycopeptide recognition domains of P-selectin glycoprotein ligand 1 and their binding to P- and E-selectin. Angew Chem Int Ed Engl 48:3174-3178
14. Marathe DD, Buffone A Jr, Chandrasekaran EV, Xue J, Locke RD, Nasirikenari M, Lau JT, Matta KL, Neelamegham S (2010) Fluorinated per-acetylated GalNAc metabolically alters glycan structures on leukocyte PSGL-1 and reduces cell binding to selectins. Blood 115:1303-1312
15. Thomas GM, Panicot-Dubois L, Lacroix R et al (2009) Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo. JEM 206(9):1913-1927
16. Chambers AF, Naumov GN, Varghese HJ, Nadkarni KV, MacDonald IC, Groom AC (2001) Critical steps in hematogenous metastasis, an overview. Surg Oncol Clin N Am 10:243-255
17. Sleeman J, Steeg PS (2010) Cancer metastasis as a therapeutic target. Eur J Cancer 46:1177-1180
18. Tsuruo T, Fujita N (2008) Platelet aggregation in the formation of tumor metastasis. Proc Jpn Acad Ser B Phys Biol Sci 84:189-198
19. Noble S, Pasi J (2010) Epidemiology and pathophysiology of cancer-associated thrombosis. Br J Cancer 102:S2-S9
20. Barthel SR, Gavino JD, Descheny L, Dimitroff CJ (2007) Targeting selectins and selectin ligands in inflammation and cancer. Expert Opin Ther Targets 11:1473-1491
21. Läubli H, Borsig L (2010) Selectins promote tumor metastasis. Semin Cancer Biol 20:169-177
22. Iiizumi M, Mohinta S, Bandyopadhyay S, Watabe K (2007) Tumor-endothelial cell interactions: Therapeutic potential. Microvasc Res 74:114-120
23. Ley K (2009) Cell adhesion under flow. Microcirculation 16:1-2
24. Fuchs B, Budde U, Schulz A, Kessler CM, Fisseau C, Kannicht C (2010) Flow-based measurements of von Willebrand factor (VWF) function: Binding to collagen and platelet adhesion under physiological shear rate. Thromb Res 125:239-245